Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey
- PMID: 25225537
- PMCID: PMC4163243
- DOI: 10.12669/pjms.305.5080
Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey
Abstract
Objective: To determine clinical features, etiology and risk factors in term and near term newborns with severe hyperbilirubinemia.
Methods: During ten years period (2000 - 2009), infants of ≥ 35 gestational weeks who received phototherapy were evaluated retrospectively. The study population was divided into two groups and clinical features, etiology and risk factors were compared. Group 1 defined by those who had bilirubin level ≥25 mg/dl (severe hyperbilirubinemia) and group 2 defined by bilirubin level <25 mg/dl.
Results: During the study period 1335 babies were evaluated. Severe hyperbilirubinemia was found in 137 (10.3%) patients. Total serum bilirubin level was 29.7±4.7 mg/dl in group 1 and 18.9±3.5 mg/dl in group 2. Pathological weight loss, vaginal delivery and supplementary feeding were identified as significant risk factors for development of severe hyperbilirubinemia (p <0.001, p <0.001 and p = 0.04, respectively). The time at recognition of jaundice by family and postnatal age at admission were significantly higher in group 1. The ratios of previous sibling received phototherapy and being the second child or after were found higher in group 1.
Conclusion: Pathological weight loss, vaginal delivery and supplementary feeding were determined as risk factors for development of severe hyperbilirubinemia. The newborns with severe hyperbilirubinemia had late recognition of jaundice and admission to hospital by their families.
Keywords: Feeding; Hyperbilirubinemia; Newborn; Risk factors.
Similar articles
-
An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.Pediatrics. 2002 Apr;109(4):e53. doi: 10.1542/peds.109.4.e53. Pediatrics. 2002. PMID: 11927726 Clinical Trial.
-
Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns.Pediatrics. 2004 Apr;113(4):775-80. doi: 10.1542/peds.113.4.775. Pediatrics. 2004. PMID: 15060227
-
Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.Pediatrics. 2001 Dec;108(6):1374-7. doi: 10.1542/peds.108.6.1374. Pediatrics. 2001. PMID: 11731664
-
Is breastfeeding really favoring early neonatal jaundice?Pediatrics. 2001 Mar;107(3):E41. doi: 10.1542/peds.107.3.e41. Pediatrics. 2001. PMID: 11230622
-
Hyperbilirubinemia in the term newborn.Am Fam Physician. 2002 Feb 15;65(4):599-606. Am Fam Physician. 2002. PMID: 11871676 Review.
Cited by
-
Relationship between asymptomatic rotavirus infection and jaundice in neonates: a retrospective study.BMC Pediatr. 2018 Nov 30;18(1):376. doi: 10.1186/s12887-018-1352-z. BMC Pediatr. 2018. PMID: 30501619 Free PMC article.
-
Maternal blood parameters and risk of neonatal pathological jaundice: a retrospective study.Sci Rep. 2023 Feb 14;13(1):2627. doi: 10.1038/s41598-023-28254-3. Sci Rep. 2023. PMID: 36788268 Free PMC article.
References
-
- Brown AK, Damus K, Kim MH, King K, Harper R, Campbell D, et al. Factors relating to readmission of term and near-term neonates in the first two weeks of life. Early Discharge Survey Group of the Health Professional Advisory Board of the Greater New York Chapter of the March of Dimes. J Perinat Med. 1999;27(4):263–275. doi:10.1515/JPM.1999.037. - PubMed
-
- Bulbul A, Okan F, Uslu S, Isci E, Nuhoglu A. Clinical characteristics of term newborns with hiperbilirubinemia and identification of the risk factors for hiperbilirubinemia. Turk Arch Ped. 2005;40:204–210.
-
- Bulbul A, Okan F, Kabakoglu Unsur E, Nuhoglu A. Adverse events associated with exchange transfusion and etiology of severe hyperbilirubinemia in near-term and term newborns. Turk J Med Sci. 2011;41(1):93–100. doi:10.3906/sag-0911-395.
-
- American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114(1):297–316. doi: 10.1542/peds.114.1.297. - PubMed
LinkOut - more resources
Full Text Sources